Xtant Medical Holdings, Inc.
XTNTAs of the close on Sep 18, 2026
Price
$0.32
Market cap
$44.9M
P/E (diluted TTM)
—
Not meaningful: the last four quarters were a loss
EPS (TTM)
−$0.08
Four quarters to Jun 30, 2026
Dividend yield
—
Dividend records do not yet cover the latest payments
Figures shown here come from public SEC filings. Dates beside each section show the available history.
How Xtant Medical Holdings, Inc. Makes Money
Follow each dollar of revenue through to what shareholders keep.
From revenue to net income
Pick a year or quarter. Each band's width is its dollar amount.
Financial Summary
Choose a year or quarter, compare it with the same period a year earlier, and open any row for its full filing history.
Loading financial history…
SEC filings supply these figures; updates after the dates shown are not included. This page includes 16 annual periods. The latest annual period ends Dec 31, 2025. The latest insider filing shown is dated Feb 18, 2026. The latest institutional report shown is dated Mar 31, 2026; other ownership filings may exist.
Ownership
Who holds the shares, as reported in SEC ownership filings.
Reported 13F positions
Each row shows what a filer reported for one date, not a current position. The link opens that filing.
| Filer | Report date | Shares | Value | Filing |
|---|---|---|---|---|
| Hillsdale Investment Management Inc. | 2026-03-31 | 362,200 | $202K | SEC filing |
| SBI Securities Co., Ltd. | 2026-03-31 | 2 | $1 | SEC filing |
| ACADIAN ASSET MANAGEMENT LLC | 2026-03-31 | 180,299 | Not shown | SEC filing |
| Tradition Wealth Management, LLC | 2026-03-31 | 100,297 | $56K | SEC filing |
| GEODE CAPITAL MANAGEMENT, LLC | 2026-03-31 | 529,214 | $295K | SEC filing |
| STATE STREET CORP | 2026-03-31 | 31,266 | $17.4K | SEC filing |
| BlackRock, Inc. | 2026-03-31 | 115,782 | $64.6K | SEC filing |
| Crescent Grove Advisors, LLC | 2026-03-31 | 412,024 | $230K | SEC filing |
| AWM Investment Company, Inc. | 2026-03-31 | 5,976,910 | $3.34M | SEC filing |
| Equitable Holdings, Inc. | 2026-03-31 | 11,450 | Not shown | SEC filing |
| CITADEL ADVISORS LLC | 2026-03-31 | 161,011 | $89.8K | SEC filing |
| Private Advisor Group, LLC | 2026-03-31 | 85,000 | $47.4K | SEC filing |
| NORTHERN TRUST CORP | 2026-03-31 | 99,598 | $55.6K | SEC filing |
| NANO CAP NEW MILLENNIUM GROWTH FUND L P | 2026-03-31 | 350,000 | $195K | SEC filing |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 2026-03-31 | 164,100 | $91.6K | SEC filing |
| MassMutual Private Wealth & Trust, FSB | 2026-03-31 | 2,000 | $1.12K | SEC filing |
| MORGAN STANLEY | 2026-03-31 | 1,125 | $628 | SEC filing |
| JANE STREET GROUP, LLC | 2026-03-31 | 33,978 | $19K | SEC filing |
| MILLENNIUM MANAGEMENT LLC | 2026-03-31 | 132,354 | $73.9K | SEC filing |
| Mink Brook Asset Management LLC | 2026-03-31 | 109,466 | $61.1K | SEC filing |
- Each value is checked against Xtant Medical Holdings, Inc.'s share prices from within about three months of its report date (insiders' Form 4 trades and the latest close).
- Value not shown for 1 row: the filed value is about 1,000 times too small for the share count at Xtant Medical Holdings, Inc.'s share price.
- Value not shown for 1 row: the value per share could not be confirmed against the share prices on file from within three months of the report date.
Filer report history
Two reports per filer, as filed. No change is calculated, because the data on file cannot confirm that both reports describe the same security.
- VALLEY WEALTH MANAGERS, INC.: 298 shares reported 2025-12-31; 298 shares reported 2026-03-31.
- WELLS FARGO & COMPANY/MN: 0 shares reported 2025-12-31; 488 shares reported 2026-03-31.
- TWO SIGMA SECURITIES, LLC: 77,350 shares reported 2025-12-31; 10,000 shares reported 2026-03-31.
- Tower Research Capital LLC (TRC): 4,616 shares reported 2025-12-31; 7,388 shares reported 2026-03-31.
- WIREGRASS INVESTMENT MANAGEMENT LLC: 103,000 shares reported 2025-12-31; 103,000 shares reported 2026-03-31.
- RENAISSANCE TECHNOLOGIES LLC: 919,860 shares reported 2025-12-31; 987,410 shares reported 2026-03-31.
- LAZARD ASSET MANAGEMENT LLC: 22,720 shares reported 2025-12-31; 19,562 shares reported 2026-03-31.
- Nantahala Capital Management, LLC: 68,394,000 shares reported 2025-12-31; 68,394,000 shares reported 2026-03-31.
- Kestra Advisory Services, LLC: 20,000 shares reported 2025-12-31; 20,000 shares reported 2026-03-31.
- Mink Brook Asset Management LLC: 109,466 shares reported 2025-12-31; 109,466 shares reported 2026-03-31.
- MILLENNIUM MANAGEMENT LLC: 190,846 shares reported 2025-12-31; 132,354 shares reported 2026-03-31.
- JANE STREET GROUP, LLC: 19,206 shares reported 2025-12-31; 33,978 shares reported 2026-03-31.
Showing the 12 most recent filer reports.
9 filers have only one report here.
Unusually large insider trades
Each trade is compared with the other insider trades of the same kind in the same security among Xtant Medical Holdings, Inc.'s recent filings on file. Size alone is context, not a prediction or evidence of improper trading.
- 2018-02-14 · Eggenberg Michael: Larger than 21 of the 23 other insider purchases of Common Stock on file. SEC filing
- 2018-02-14 · Rizzo Matthew: Larger than 21 of the 23 other insider purchases of Common Stock on file. SEC filing
- 2018-02-14 · ORBIMED ADVISORS LLC: Larger than 21 of the 23 other insider purchases of Common Stock on file. SEC filing
Independent insiders buying near the same time
- 2018-02-14–2018-02-14: 6 event(s) across 3 owner(s) — A cluster counts independent reporting owners that reported purchases within a set time. Co-filers and declared affiliates count once, and duplicate reports of the same event count once. ( filing , filing , filing , filing , filing , filing )
- 2015-11-16–2015-11-20: 7 event(s) across 3 owner(s) — A cluster counts independent reporting owners that reported purchases within a set time. Co-filers and declared affiliates count once, and duplicate reports of the same event count once. ( filing , filing , filing , filing , filing , filing , filing )
- 2015-09-04–2015-09-04: 5 event(s) across 5 owner(s) — A cluster counts independent reporting owners that reported purchases within a set time. Co-filers and declared affiliates count once, and duplicate reports of the same event count once. ( filing , filing , filing , filing , filing )
Purchases & sales (open market or private)
| Security | Code | Price | Filing | |||
|---|---|---|---|---|---|---|
| 2025-04-10 | ORBIMED ADVISORS LLC · 10% owner | Common Stock | S — Open market or private sale | −56,004,974 | 0.42 | SEC filing |
| 2025-04-10 | ORBIMED ADVISORS LLC · 10% owner | Common Stock | S — Open market or private sale | −17,109,618 | 0.42 | SEC filing |
| 2023-11-17 | Brandt Kevin D · Chief Commercial Officer | Common Stock | P — Open market or private purchase | +41,670 | 1.20 | SEC filing |
| 2023-01-18 | Neils Scott C · Chief Financial Officer | Common Stock, $0.000001 par value | S — Open market or private sale | −8,673 | 0.61 | SEC filing |
| 2022-10-19 | Browne Sean E · President and CEO | Common Stock, $0.000001 par value | S — Open market or private sale | −51,100 | 0.62 | SEC filing |
| 2022-10-18 | Browne Sean E · President and CEO | Common Stock, $0.000001 par value | S — Open market or private sale | −80,000 | 0.68 | SEC filing |
| 2022-10-07 | Vizirgianakis Stavros G. · Director | Warrant | P — Open market or private purchase | +566,214 | 0.00 | SEC filing |
| 2022-10-07 | Vizirgianakis Stavros G. · Director | Common Stock, $0.000001 par value | P — Open market or private purchase | +2,264,861 | 0.48 | SEC filing |
Showing 8 of 19 rows
Grants, exercises, tax & gifts
| Security | Code | Filing | |||
|---|---|---|---|---|---|
| 2026-02-15 | Schallenberger Mark A. · Chief Operating Officer | Common Stock | F — Payment of exercise price or tax by delivering securities | −7,709 | SEC filing |
| 2026-01-15 | Neils Scott C · CFO and Assistant Secretary | Common Stock | F — Payment of exercise price or tax by delivering securities | −8,084 | SEC filing |
| 2025-11-15 | Beeson Jonn R. · Director | Common Stock | A — Grant, award, or other acquisition | +158,228 | SEC filing |
| 2025-11-15 | JAIN ABHINAV · Director | Common Stock | A — Grant, award, or other acquisition | +158,228 | SEC filing |
| 2025-11-15 | Browne Sean E · President and CEO | Performance Stock Units (PSUs) | A — Grant, award, or other acquisition | +789,874 | SEC filing |
| 2025-11-15 | Schallenberger Mark A. · Chief Operating Officer | Performance Stock Units (PSUs) | A — Grant, award, or other acquisition | +584,506 | SEC filing |
| 2025-11-15 | Neils Scott C · CFO and Assistant Secretary | Performance Stock Units (PSUs) | A — Grant, award, or other acquisition | +526,582 | SEC filing |
| 2025-11-15 | Schallenberger Mark A. · Chief Operating Officer | Common Stock | A — Grant, award, or other acquisition | +292,253 | SEC filing |
Showing 8 of 30 rows
Other activity
| Security | Code | Filing | |||
|---|---|---|---|---|---|
| 2022-08-15 | ORBIMED ADVISORS LLC · Director, 10% owner | Common Stock, $0.000001 par value | J — Other acquisition or disposition | +215,415 | SEC filing |
| 2021-08-15 | ORBIMED ADVISORS LLC · Director, 10% owner | Common Stock | J — Other acquisition or disposition | +85,337 | SEC filing |
| 2020-02-05 | ORBIMED ADVISORS LLC · Director, 10% owner | Common Stock, $0.000001 par value | J — Other acquisition or disposition | +70,423 | SEC filing |
| 2019-10-30 | ORBIMED ADVISORS LLC · Director, 10% owner | Common Stock, $0.000001 par value | J — Other acquisition or disposition | +20,833 | SEC filing |
| 2018-02-14 | Rizzo Matthew · Director, 10% owner | Convertible Note | D — Disposition to the issuer | −unknown | SEC filing |
| 2018-02-14 | Eggenberg Michael · Director, 10% owner | Convertible Note | D — Disposition to the issuer | −unknown | SEC filing |
| 2018-02-14 | Rizzo Matthew · Director, 10% owner | Convertible Note | D — Disposition to the issuer | −unknown | SEC filing |
| 2018-02-14 | ORBIMED ADVISORS LLC · Director, 10% owner | Convertible Note | D — Disposition to the issuer | +809,614 | SEC filing |
Showing 8 of 10 rows
These tables describe filed transactions, not current holdings. Prices are shown as filed; a currency is added only when the filing's data names one. Amended and possible duplicate rows are left out of size comparisons and transaction groups.